Course Description:

It is estimated that at least 50% of people post-menopause will experience the vulvovagina, urinary, and sexual signs and symptoms associated with the new term, “Genitourinary Syndrome ofMenopause” (GSM). Yet<50% of patients will discuss symptoms with their healthcare provider, and we have a paucity of healthcare providers with knowledge to adequately assess and treat this chronic and progressive issue.

Learning Objectives:

1. Understand the prevalence and consequences of GSM
2. Explain the pathophysiology of GSM
3. Clinically screen for symptoms of GSM from patient screening questions to vulvovaginal examination
4. Perform a vulvar exam to assess for clinical signs of GSM
5. Manage GSM using evidence-based treatment recommendations, including safely prescribing hormone therapy
6. Counsel your patient about treatment options

This session is approved for 0.75 General, 0.75 Pharmacology Category A CE Credits CE Credits with the College of Naturopaths of Ontario (CONO).  After completing the material, you will automatically receive your CE certificate.

Special Thanks to our Sponsor for this session